XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities    
Net loss $ (22,497) $ (24,312)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 126 523
Non-cash lease expense 739 653
Stock-based compensation expense 1,803 2,746
Change in fair value of derivative related to Term Loan with related party (1,130) (252)
Change in fair value of warrant liabilities 152 (5,888)
Issuance costs related to Common Stock Warrants   682
Loss on disposal of property and equipment 21 3
Non-cash interest expense to related party 362 1,050
Changes in operating assets and liabilities:    
Accounts receivable 123 814
Prepaid expenses and other assets 974 574
Inventories (350) (374)
Accounts payable 159 938
Accrued expenses and other liabilities (629) (1,936)
Deferred revenue 4 105
Operating lease liabilities (781) (653)
Net cash used in operating activities (20,924) (25,327)
Cash flows from investing activities    
Purchases and manufacture of property and equipment   (153)
Net cash used in investing activities   (153)
Cash flows from financing activities    
Payment of employee restricted stock tax withholdings (1)  
Proceeds from issuance of shares from employee stock purchase plan and stock option exercises 10 2
Proceeds from public offering, net of issuance costs   10,918
Proceeds from private offering, net of issuance costs 7,269  
Proceeds from secondary offering, net of issuance costs 2,203 19,315
Net cash provided by financing activities 9,481 30,235
Net change in cash, cash equivalents and restricted cash (11,443) 4,755
Cash, cash equivalents and restricted cash at beginning of period 16,240 11,880
Cash, cash equivalents and restricted cash at end of period 4,797 16,635
Reconciliation of cash, cash equivalents and restricted cash at end of period    
Cash and cash equivalents 4,246 16,084
Restricted cash 551 551
Total cash, cash equivalents and restricted cash 4,797 16,635
Supplemental disclosures of cash flow information    
Cash paid for interest to related party 1,677 2,005
Supplemental disclosures of noncash activities    
Transfer of T2 owned instruments and components from inventory   (322)
Cashless exercise of Common Stock Warrants   (1,448)
Cancellation of Term Loan in exchange for common stock and Convertible Preferred Stock to related party 33,353  
Wainwright Warrant issued in connection with offering costs of May 2024 private offering $ 747  
Purchases of property and equipment included in accounts payable and accrued expenses   $ 131